Risk factors for breast cancer from benign breast disease in a diverse population

被引:36
|
作者
Worsham, Maria J. [1 ]
Raju, Usha [2 ]
Lu, Mei [3 ]
Kapke, Alissa [3 ]
Botttrell, Alyssa [1 ,4 ]
Cheng, Jingfang [5 ]
Shah, Varsha [6 ]
Savera, Adnan [7 ]
Wolman, Sandra R. [8 ]
机构
[1] Henry Ford Hlth Syst, Dept Otolaryngol Head & Neck Surg, Detroit, MI 48202 USA
[2] Henry Ford Hlth Syst, Dept Pathol, Detroit, MI 48202 USA
[3] Henry Ford Hlth Syst, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA
[4] Wayne State Univ, Detroit, MI USA
[5] Henry Ford Hlth Syst, Wayne State Sch Med, Dept Head & Neck Surg, Detroit, MI 48202 USA
[6] Royal Gwent Hosp, Newport, Gwent, Wales
[7] LabMD Inc, Atlanta, GA USA
[8] George Washington Univ, Dept Pathol, Washington, DC 20052 USA
关键词
Benign breast disease; Progression; Risk factors; ATYPICAL HYPERPLASIA; EXOGENOUS ESTROGENS; CARCINOMA RISK; WOMEN; BIOPSY; AGE; DIAGNOSIS; ETHNICITY; COHORT; FIBROADENOMAS;
D O I
10.1007/s10549-008-0198-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background The majority of studies have reported risks of breast cancer (BC) from benign breast disease (BBD) in essentially homogenous Caucasian populations. Information on breast cancer risk factors in larger, multi-ethnic populations should facilitate the development of appropriate and targeted risk reduction strategies. Design Cases and controls were drawn from a parent BBD cohort of 4,970 women, 1,341 African-Americans (AA) and 3,629 non-AA who were diagnosed with BBD after examination of an excisional breast biopsy. Risk factors (34 variables) included demographics, lesion types, and epidemiological variables. Results The final multivariable model retained significance (P < 0.05) for lesion risk-level, fibroadenoma, and the interaction of age-by-race. Women with proliferative lesions (no atypia, risk level 2) were 1.7 times more likely to develop BC when compared with women with non-proliferative lesions (OR = 1.7, 95% CI 1.13, 2.42, P = 0.009). Women with atypia (risk level 3) were 3.75 times more likely to develop BC compared to women with non-proliferative lesions (OR = 3.75, 95% CI 1.99, 7.06, P < 0.001). The odds of breast cancer was approximately 35% lower among women with fibroadenoma as compared to women without fibroadenoma (OR = 0.65, 95% CI 0.46, 0.94, P = 0.020). AA women with BBD who were 50 years or older were 2.28 times more likely to develop breast cancer as compared to non-AA women who were less than 50 years old (OR = 2.28, 95% CI 1.34, 3.88, P = 0.002). Conclusion Women with fibroadenoma (nonproliferative or proliferative) were less likely to progress to BC. Older AA women are at greater risk for progression to breast cancer from BBD.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 50 条
  • [31] Benign breast disease and risk of thyroid cancer
    Luo, Juhua
    Hendryx, Michael
    Nassir, Rami
    Cheng, Ting-Yuan David
    Lane, Dorothy
    Margolis, Karen L.
    CANCER CAUSES & CONTROL, 2017, 28 (09) : 913 - 920
  • [32] Benign breast disease and risk of thyroid cancer
    Juhua Luo
    Michael Hendryx
    Rami Nassir
    Ting-Yuan David Cheng
    Dorothy Lane
    Karen L. Margolis
    Cancer Causes & Control, 2017, 28 : 913 - 920
  • [33] Benign breast disease and breast cancer
    Koss, LG
    Fineberg, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17): : 1856 - 1856
  • [34] Benign Breast Disease and Breast Cancer Risk in the Percutaneous Biopsy Era
    Sherman, Mark E.
    Vierkant, Robert A.
    Winham, Stacey J.
    Vachon, Celine M.
    Carter, Jodi M.
    Pacheco-Spann, Laura
    Jensen, Matthew R.
    McCauley, Bryan M.
    Hoskin, Tanya L.
    Seymour, Lisa
    Gehling, Denice
    Fischer, Jessica
    Ghosh, Karthik
    Radisky, Derek C.
    Degnim, Amy C.
    JAMA SURGERY, 2024, 159 (02) : 193 - 201
  • [35] HISTOLOGIC TYPES OF BENIGN BREAST DISEASE AND THE RISK FOR BREAST-CANCER
    MCDIVITT, RW
    STEVENS, JA
    LEE, NC
    WINGO, PA
    RUBIN, GL
    GERSELL, D
    CANCER, 1992, 69 (06) : 1408 - 1414
  • [36] The Evolving Era of Breast Cancer Risk Assessment in Benign Breast Disease
    Dalton, Juliet C.
    Chiba, Akiko
    Plichta, Jennifer K.
    JAMA SURGERY, 2024, 159 (02) : 178 - 178
  • [37] BENIGN BREAST DISEASE AND THE RISK OF BREAST CANCER IN THE NEXT 15 YEARS
    Socolov, Demetra
    Lupascu, Ivona Anghelache
    Ilea, C.
    Socolov, R.
    Carauleanu, A.
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2015, 119 (01): : 135 - 140
  • [38] Benign breast disease and subsequent breast cancer risk: The Detroit cohort
    Cote, Michele L.
    Chen, Wei
    Ruterbusch, Julie J.
    Abdulfatah, Eman
    Pardeshi, Visakha
    Shaik, Asra N.
    Ghanim, Marcel T.
    Daaboul, M. H. D. Fayez
    Visscher, Daniel W.
    Bandyopadhyay, Sudeshna
    Ali-Fehmi, Rouba
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2017, 26 (05)
  • [39] Characterizing benign breast disease in women at high risk for breast cancer
    Israel, S. A.
    Nassar, H.
    Gross, A. L.
    Jacobs, L. K.
    Armstrong, D. K.
    Visvanathan, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [40] Benign breast disease and microcalcifications in percutaneous biopsies and breast cancer risk
    Schrup, Sarah
    Vierkant, Robert
    Winham, Stacey
    Vachon, Celine
    Radisky, Derek
    Carter, Jodi
    Pacheco-Spann, Laura
    Jensen, Matthew
    Degnim, Amy
    Sherman, Mark
    CANCER RESEARCH, 2024, 84 (09)